18th Dec 2017 16:21
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Dr P J T Vallance | ||||
b) | Position/status | President, R&D | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||
b) | Nature of the transaction | Sale of 20,000 Ordinary shares on 18 December 2017 at a price of £13.1044. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
Aggregated volume Price | n/a (single transaction) | ||||
e) | Date of the transaction | 2017-12-18 | ||||
f) | Place of the transaction
| London Stock Exchange, Main Market (XLON) | ||||
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Mrs S Vallance | ||||
b) | Position/status | PCA of Dr P J T Vallance (President, R&D) | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
| ||||
b) | Nature of the transaction | Sale of 32,974 Ordinary shares on 18 December 2017 at a price of £13.0911 | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
Aggregated volume Price | n/a (single transaction)
| ||||
e) | Date of the transaction | 2017-12-18 | ||||
f) | Place of the transaction
| London Stock Exchange, Main Market (XLON) | ||||
Related Shares:
Glaxosmithkline